Table 4.

Clinical adjudication based on expert chart review in 6 patients with Possible IMX-BVN-3 bacterial scores

ID	IMX-BVN-3 bacterial result	IMX-BVN-3 viral result	IMX-SEV-3 severity result	Clinical characteristics	Microbiology findings	Antimicrobial therapy and other data	Discharge diagnoses	Bacterial infection
0076	Possible	Very Unlikely	Moderate	Septic shock on admission	Positive (C. difficile toxin in stool)	Cefepime, vancomycin, fidaxomycin, metronidazole	Septic shock; C. difficile colitis	Co-infection
0082	Possible	Possible	Moderate	Hypoxic respiratory failure, hypotension	Negative	Cefepime azithromycin, vancomycin	Septic shock; bacterial pneumonia, viral pneumonia	Co-infection (bacterial pneumonia diagnosed clinically)
0281	Possible	Unlikely	Moderate	Abdominal pain	Positive (Urine culture positive for viridans streptococci)	Ertapenem, cefepime, metronidazole	COVID-19; abdominopelvic abscess	Co-infection (gastrointestinal perforation with peritonitis and fecal pathogens in urine)
0397	Possible	Possible	Moderate	Hypoxic respiratory failure, persistent leukocytosis	Negative	Azithromycin, ceftriaxone	Persistent leukocytosis	Co-infection (bacterial infection, improved with antibiotics suspected by ID consult)
0477	Possible	Possible	Moderate	Shortness of breath, hypoxia, SIRS	Negative	Eefepime, caspofungin	Sepsis; Leukemia with graft vs. host disease	Co-infection (bacterial infection, treated with antibiotics suspected by ID consult)
0500	Possible	Very Unlikely	Moderate	Fall	Negative	None used on admission	Asymptomatic COVID-19 infection	Negative